Import Addiction: Why India Still Buys 70% of Its Devices Abroad

Introduction: The Paradox of India’s MedTech Growth

India’s medical devices industry is celebrated as one of the fastest-growing globally, expanding from USD 11 billion in 2023 to a projected USD 50 billion by 2030 , a 15–20% CAGR that makes it one of the hottest healthcare sectors worldwide.

But beneath the headlines lies a paradox: while India is on track to become a $50B MedTech powerhouse, nearly 70% of its devices are still imported. Advanced diagnostic imaging systems, robotic surgical tools, ICU monitors, and even basic implants continue to come from international giants such as GE, Philips, Siemens, and Medtronic.

This heavy reliance on foreign suppliers has created an “import addiction” that makes the country vulnerable to global supply shocks, exposes hospitals and patients to higher treatment costs, and slows down the growth of a truly self-reliant domestic ecosystem.

The big question is: why does India - a country that can build satellites, cars, and fighter jets - still depend on foreign players for critical medical devices?

The Scale of Import Dependence

The numbers tell a stark story:

• India accounts for just ~1.5% of the global MedTech market, compared to China (14%) and the United States (40%).

• In 2023 alone, India imported over USD 7 billion worth of devices.

Dependence is highest in categories like:

• Diagnostic Imaging: X-rays, CT scans, and MRIs, where India^[1] manufactures less than 15% of local demand.

• Surgical Instruments: Robotic systems and advanced endoscopes, largely imported from the US, EU, and Japan.

• Monitoring Systems: ICU devices, ventilators, and cardiac monitors.

• High-End Consumables: Stents, orthopedic implants, and dialysis kits.

India has domestic strength in low-value consumables such as syringes, gloves, and disposables, but the high-value segment which captures both revenue and innovation remains dominated by imports.

Why India Still Imports 70% of Its Devices

1. High Capital Intensity & R&D Barriers
MedTech is not like manufacturing textiles or auto parts. Producing a single MRI machine requires:

• Precision engineering comparable to aerospace.

• Cleanroom facilities for sterile assembly.

• Years of R&D testing and regulatory trials.

• Deep collaboration between engineers, doctors, and clinical researchers.

2. Most Indian MedTech firms are SMEs with limited funding. Unlike global players that invest billions into R&D pipelines, Indian companies often focus on quicker-to-market products like syringes or diagnostic strips.

3. Regulatory Complexity & Global Certification Gaps
India’s Medical Devices Rules (MDR 2020) improved patient safety but increased compliance costs. To export globally, firms must also meet US FDA and CE certifications, which require extensive clinical validation and documentation. For smaller firms, this is a mountain too steep to climb.

4. Weak Ecosystem Integration
Unlike in China, where government-led clusters connect suppliers, R&D labs, and manufacturers, India’s MedTech ecosystem remains fragmented. Many components (sensors, microchips, high-grade polymers) are still imported, keeping the final product dependent on global supply chains.

5. Doctor & Hospital Brand Bias
Perception matters in healthcare. Hospitals often prefer internationally branded devices, associating them with reliability, accuracy, and global reputation. Even when Indian devices meet technical standards, doctors are reluctant to switch, reinforcing dependence on imports.

6. Policy Gaps & Late Start
Initiatives like the PLI scheme and MedTech Parks were only launched recently. By contrast, China began aggressively investing in its MedTech ecosystem more than a decade ago, offering massive subsidies and export incentives. India is catching up, but the lag shows.

The Risks of Import Addiction

1. Vulnerability to Global Supply Chains
During COVID-19, India faced critical shortages of ventilators, PPE, and oxygen devices because imports stalled. This dependence is not just an economic weakness but also a national security risk.

2. High Healthcare Costs for Patients
Imported devices are 30–80% more expensive due to shipping, duties, and brand mark-ups. With 48% of healthcare spending in India being out-of-pocket, this makes advanced treatments inaccessible for millions.

3. Weak Investor Confidence in Local Startups
If imports dominate, why would investors fund local innovators? This creates a vicious cycle where capital avoids Indian MedTech firms, slowing their ability to innovate.

4. Lost Export Opportunities
India is perfectly positioned to export affordable MedTech to Africa, GCC, and Southeast Asia regions that need low-cost healthcare solutions. But without a domestic base in high-value devices, this export window may close in favor of China or other Asian peers.

Why Domestic Manufacturing Hasn’t Taken Off (Yet)

• Fragmented Industry: 70% of local firms operate in the low-value consumables space.

• Lack of Scale: Very few Indian players have global-scale facilities.

• Talent Shortage: India produces excellent engineers, but biomedical R&D talent and regulatory experts remain scarce.

• Capital Constraints: MedTech requires patient, long-term funding. India’s high borrowing costs and limited venture capital interest keep growth sluggish.

What’s Changing: Policy & Ecosystem Shifts

1. Production-Linked Incentive (PLI) Scheme
With USD 1B+ allocated, the PLI program incentivises domestic production of critical devices from imaging machines to implants.

2. MedTech Parks
Four dedicated parks in AP, Telangana, TN, and Himachal Pradesh provide infrastructure, testing labs, and R&D support, reducing startup entry barriers.

3. Make in India + NDHM Integration
The government is aligning MedTech growth with Ayushman Bharat and the National Digital Health Mission, creating standardised adoption frameworks that will favor locally produced devices.

4. Global-Local Partnerships
MNCs like Siemens and Medtronic are building India-based manufacturing and R&D centers. This “local for global” strategy could accelerate India’s ecosystem maturity.

The Path to Self-Reliance: How India Can Reduce Import Dependence

1. Invest in Precision Engineering
Leverage expertise from automotive, aerospace, and electronics to create globally competitive MedTech devices.

2. Encourage Startups & SMEs
Build MedTech incubators, accelerators, and grant programs to support next-gen innovators.

3. Scale Manufacturing & Supply Chains
Create integrated supply clusters that reduce reliance on imported sensors, polymers, and chips.

4. Boost Investor Confidence
Provide export incentives, tax breaks, and transparency in regulatory approvals to attract domestic and foreign capital.

5. Educate Doctors & Hospitals
Launch national awareness campaigns to shift hospital procurement practices and promote adoption of safe, high-quality Indian devices.

Who Will Lead the Shift?

• Domestic Innovators: Startups developing low-cost diagnostics, IoT wearables, and portable imaging solutions.

• Established Manufacturers: Large Indian firms scaling up production under PLI.

• Global Giants: Multinationals setting up Indian hubs to serve both local and export markets.

• Investors: PE/VC funds betting on the “China+1” opportunity in MedTech manufacturing.

Conclusion: Breaking Free from Import Addiction

India’s 70% dependence on imported medical devices is both a challenge and a strategic opportunity. On one side, it exposes the country to supply disruptions, unaffordable costs, and missed innovation. On the other hand, it opens a chance to build a world-class MedTech hub leveraging India’s proven manufacturing capabilities, government incentives, and digital healthcare backbone.

If India can align policy, capital, and talent, it will not only serve its own domestic needs but also emerge as the affordable MedTech supplier for the Global South. Breaking this “import addiction” is not just about saving costs, it is about healthcare sovereignty, patient access, and global leadership.

FAQs

1. Why does India import 70% of its medical devices?
Because of high R&D costs, lack of local component ecosystems, regulatory hurdles, and hospital preference for foreign brands.

2. Which devices are most import-dependent?
MRI and CT machines, robotic surgical systems, ICU monitors, implants, and high-end consumables.

3. What are the risks of import dependence?
Supply chain disruption, higher costs for patients, weak investor confidence, and missed exports.

4. What steps is the government taking?
PLI scheme, MedTech Parks, Make in India, and NDHM integration.

5. Can India realistically become self-reliant?
Yes, by investing in engineering, scaling local manufacturing, building clusters, and shifting hospital procurement to domestic devices.

1. India - Link ↑